Abbott Laboratories
ABTDividend King • 52yrsAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Abbott Laboratories (ABT) operates in the Medical Devices industry and is based in the United States. It pays a quarterly dividend of $2.52 a year, a yield of 2.43% at the current price of $103.70. Abbott Laboratories has raised its dividend for 52 consecutive years, which makes it a Dividend King. Over the last five years the dividend has grown by an average of 10.4% a year. It paid out 79% of its earnings as dividends. 27 analysts cover it; their average 12-month price target of $118.64 is 14.4% above the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.